Abstract
Skin advanced glycation end products (AGEs) may better correlate with diabetes control, duration and complications than serum AGEs, as they reflect long-term tissue accumulation. We evaluated whether, in individuals with type 1 diabetes (T1D): 1). skin AGEs correlate with serum AGEs; 2). AGEs correlate with HbA1c and diabetes duration; 3). AGEs differ in those with microvascular complications from those without.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
